New mechanism identified disarms the macrophages that attack the immune cells. A substance called Gdf-15 released by pancreatic tumor cells suppresses macrophage during early tumor development, reveals a new study.
The study found that the substance Gdf-15, might be required for the development of early pancreatic tumors. The research also revealed that a molecule pronounced N-F-kappa-B (NF-kB) helps tumor cells produce Gdf-15.
Pancreatic Cancer
Pancreatic cancer often involves its exocrine part. It grows aggressively, and often detected late. Treatment options include surgery, radiation and chemotherapy.
Advertisement
‘GDF-15 released from pancreatic tumor cells inhibits NF-kB activity in macrophages that blocks them from killing tumor cells.’
Tweet it Now
The new study was by researchers at The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute (OSUCCC - James).
When macrophages take up Gdf-15, it prevents them making nitric oxide and tumor necrosis factor, two chemicals they release to kill cancer cells. Ironically, the researchers found that NF-kB in macrophages plays an important role in the production of nitric oxide and tumor necrosis factor.
![An Electronic Nose to Detect Pancreatic Cancer]( "An Electronic Nose to Detect Pancreatic Cancer")
An electronic nose could be an efficient screening method for the diagnosis of pancreatic cancer, says study.
The findings are reported in the Journal of Clinical Investigation.
"This study shows that GDF-15 plays an important role in the development of pancreatic cancer and might be required for the development of early pancreatic tumors," says principal investigator Denis Guttridge, PhD, professor of Cancer Biology and Genetics at Ohio State and associate director for basic research.
"We believe that this mechanism for disarming macrophages develops early in cancer cells, enabling small tumors to survive and grow," adds Guttridge, who also is in the OSUCCC - James Molecular Carcinogenesis and Chemoprevention Program.
"These findings support the need for preclinical studies to determine the role of GDF-15 in the development of pancreatic cancer."
Guttridge and his colleagues conducted the study using pancreatic-cancer cell lines, cells from patient tumors and an animal model.
Key findings include:
"Overall," Guttridge says, "our results reveal that NF-kB is responsible for the synthesis and secretion of GDF-15 from pancreatic tumor cells, and that GDF-15 then inhibits NF-kB activity in macrophages and blocks them from killing tumor cells."
Source: Eurekalert
An Electronic Nose to Detect Pancreatic Cancer
An electronic nose could be an efficient screening method for the diagnosis of pancreatic cancer, says study.
Advertisement
The findings are reported in the Journal of Clinical Investigation.
"This study shows that GDF-15 plays an important role in the development of pancreatic cancer and might be required for the development of early pancreatic tumors," says principal investigator Denis Guttridge, PhD, professor of Cancer Biology and Genetics at Ohio State and associate director for basic research.
"We believe that this mechanism for disarming macrophages develops early in cancer cells, enabling small tumors to survive and grow," adds Guttridge, who also is in the OSUCCC - James Molecular Carcinogenesis and Chemoprevention Program.
"These findings support the need for preclinical studies to determine the role of GDF-15 in the development of pancreatic cancer."
Guttridge and his colleagues conducted the study using pancreatic-cancer cell lines, cells from patient tumors and an animal model.
Key findings include:
- NF-kB is a direct regulator of Gdf-15
- GDF-15 suppresses macrophage cell-killing activity by inhibiting the production of nitric oxide and tumor necrosis factor
- Both GDF-15 and NF-kB are overexpressed in patients with pancreatic cancer
"Overall," Guttridge says, "our results reveal that NF-kB is responsible for the synthesis and secretion of GDF-15 from pancreatic tumor cells, and that GDF-15 then inhibits NF-kB activity in macrophages and blocks them from killing tumor cells."
Source: Eurekalert
World Pancreatic Cancer Day 2017: Demand Better. For Patients. For Survival
The World Pancreatic Cancer Day is being celebrated on November 16, 2017, aims to early diagnosis and improve outcomes for the patient.
Advertisement
Advertisement
|
Advertisement
Recommended Readings
Latest Cancer News
The combination of the personalized cancer vaccine with ACT led to ovarian cancer control in few patients within a span of three months, stated study results.
Uncovering key kinases in tumor growth and invasion is crucial for improving targeted therapies in advanced-stage colorectal cancer.
The study findings validate metal-enhanced photo-oxidation for future metal-based anticancer drugs.
Mutations in 11 genes are linked to aggressive forms of prostate cancer, which may present novel therapeutic and therapy options.
Improved oral health, as indicated by the count of natural teeth and dental appointments preceding the diagnosis, correlated with enhanced head and neck cancer survival rates.
